Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

Similar articles for PubMed (Select 14500779)

1.

Human hepatic CYP2E1 expression during development.

Johnsrud EK, Koukouritaki SB, Divakaran K, Brunengraber LL, Hines RN, McCarver DG.

J Pharmacol Exp Ther. 2003 Oct;307(1):402-7. Erratum in: J Pharmacol Exp Ther. 2004 Apr;309(1):439.

2.
3.
4.

Modeling interchild differences in pharmacokinetics on the basis of subject-specific data on physiology and hepatic CYP2E1 levels: a case study with toluene.

Nong A, McCarver DG, Hines RN, Krishnan K.

Toxicol Appl Pharmacol. 2006 Jul 1;214(1):78-87. Epub 2006 Feb 7.

PMID:
16464483
5.

Developmental changes in human liver CYP2D6 expression.

Stevens JC, Marsh SA, Zaya MJ, Regina KJ, Divakaran K, Le M, Hines RN.

Drug Metab Dispos. 2008 Aug;36(8):1587-93. doi: 10.1124/dmd.108.021873. Epub 2008 May 12.

6.

Tobacco smoke-dependent changes in cytochrome P450 1A1, 1A2, and 2E1 protein expressions in fetuses, newborns, pregnant rats, and human placenta.

Czekaj P, Wiaderkiewicz A, Florek E, Wiaderkiewicz R.

Arch Toxicol. 2005 Jan;79(1):13-24. Epub 2004 Sep 23.

PMID:
15448981
7.

Expression of CYP2E1 during human fetal development: methylation of the CYP2E1 gene in human fetal and adult liver samples.

Jones SM, Boobis AR, Moore GE, Stanier PM.

Biochem Pharmacol. 1992 Apr 15;43(8):1876-9.

PMID:
1575782
8.

Ontogeny of hepatic CYP1A2 and CYP2E1 expression in rat.

Elbarbry FA, McNamara PJ, Alcorn J.

J Biochem Mol Toxicol. 2007;21(1):41-50.

PMID:
17366540
9.

Catalytic activity and quantitation of cytochrome P-450 2E1 in prenatal human brain.

Brzezinski MR, Boutelet-Bochan H, Person RE, Fantel AG, Juchau MR.

J Pharmacol Exp Ther. 1999 Jun;289(3):1648-53.

10.

Ontogeny of human hepatic cytochromes P450.

Hines RN.

J Biochem Mol Toxicol. 2007;21(4):169-75. Review.

PMID:
17936930
11.

Developmental expression of human hepatic CYP2C9 and CYP2C19.

Koukouritaki SB, Manro JR, Marsh SA, Stevens JC, Rettie AE, McCarver DG, Hines RN.

J Pharmacol Exp Ther. 2004 Mar;308(3):965-74. Epub 2003 Nov 21.

12.

Nuclear receptor expression in fetal and pediatric liver: correlation with CYP3A expression.

Vyhlidal CA, Gaedigk R, Leeder JS.

Drug Metab Dispos. 2006 Jan;34(1):131-7. Epub 2005 Oct 21.

13.

Lymphocyte cytochrome P450-CYP2E1 expression in human IDDM subjects.

Hannon-Fletcher MP, O'Kane MJ, Moles KW, Barnett YA, Barnett CR.

Food Chem Toxicol. 2001 Feb;39(2):125-32.

PMID:
11267705
14.

Growth retardation of fetal rats exposed to nicotine in utero: possible involvement of CYP1A1, CYP2E1, and P-glycoprotein.

Wang T, Chen M, Yan YE, Xiao FQ, Pan XL, Wang H.

Environ Toxicol. 2009 Feb;24(1):33-42. doi: 10.1002/tox.20391.

PMID:
18442069
15.

Functional characterization of human and cynomolgus monkey cytochrome P450 2E1 enzymes.

Hanioka N, Yamamoto M, Iwabu H, Jinno H, Tanaka-Kagawa T, Naito S, Shimizu T, Masuda K, Katsu T, Narimatsu S.

Life Sci. 2007 Oct 27;81(19-20):1436-45. Epub 2007 Sep 15.

PMID:
17935737
16.

Variation in induction of human placental CYP2E1: possible role in susceptibility to fetal alcohol syndrome?

Rasheed A, Hines RN, McCarver-May DG.

Toxicol Appl Pharmacol. 1997 Jun;144(2):396-400.

PMID:
9194424
17.
18.
19.

Role of CYP2E1 in ketone-stimulated insulin release in pancreatic B-cells.

Murdock DJ, Clarke J, Flatt PR, Barnett YA, Barnett CR.

Biochem Pharmacol. 2004 Mar 1;67(5):875-84.

PMID:
15104240
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk